KIT and acute myeloid leukemia: In addition, AML development was driven by the branching evolution of the TET2N191Kfs*4/RUNX1R201Q_HOM clone through the acquisition of two independent mutations in the NRAS and KIT genes, with the emergence of two independent new subclones (C6 and C7, respectively).